1. Home
  2. BLCO vs EPR Comparison

BLCO vs EPR Comparison

Compare BLCO & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • EPR
  • Stock Information
  • Founded
  • BLCO 1853
  • EPR 1997
  • Country
  • BLCO Canada
  • EPR United States
  • Employees
  • BLCO N/A
  • EPR N/A
  • Industry
  • BLCO Ophthalmic Goods
  • EPR Real Estate Investment Trusts
  • Sector
  • BLCO Health Care
  • EPR Real Estate
  • Exchange
  • BLCO Nasdaq
  • EPR Nasdaq
  • Market Cap
  • BLCO 4.4B
  • EPR 4.1B
  • IPO Year
  • BLCO 2022
  • EPR 1997
  • Fundamental
  • Price
  • BLCO $13.45
  • EPR $58.46
  • Analyst Decision
  • BLCO Hold
  • EPR Hold
  • Analyst Count
  • BLCO 13
  • EPR 11
  • Target Price
  • BLCO $15.63
  • EPR $53.70
  • AVG Volume (30 Days)
  • BLCO 717.1K
  • EPR 745.0K
  • Earning Date
  • BLCO 07-30-2025
  • EPR 07-30-2025
  • Dividend Yield
  • BLCO N/A
  • EPR 6.06%
  • EPS Growth
  • BLCO N/A
  • EPR N/A
  • EPS
  • BLCO N/A
  • EPR 1.63
  • Revenue
  • BLCO $4,829,000,000.00
  • EPR $697,032,000.00
  • Revenue This Year
  • BLCO $6.97
  • EPR $4.09
  • Revenue Next Year
  • BLCO $5.48
  • EPR $2.77
  • P/E Ratio
  • BLCO N/A
  • EPR $35.81
  • Revenue Growth
  • BLCO 11.94
  • EPR 0.70
  • 52 Week Low
  • BLCO $10.45
  • EPR $41.02
  • 52 Week High
  • BLCO $21.69
  • EPR $59.31
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 69.62
  • EPR 65.35
  • Support Level
  • BLCO $12.02
  • EPR $56.50
  • Resistance Level
  • BLCO $12.31
  • EPR $59.31
  • Average True Range (ATR)
  • BLCO 0.45
  • EPR 1.05
  • MACD
  • BLCO 0.15
  • EPR -0.11
  • Stochastic Oscillator
  • BLCO 88.94
  • EPR 76.77

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

Share on Social Networks: